Your browser doesn't support javascript.
loading
Phase I clinical trials of MRX-115. A new ultrasound contrast agent.
Fritz, T A; Unger, E C; Sutherland, G; Sahn, D.
Affiliation
  • Fritz TA; ImaRx Pharmaceutical Corp., Tucson, Arizona 85719, USA.
Invest Radiol ; 32(12): 735-40, 1997 Dec.
Article in En | MEDLINE | ID: mdl-9406013
Subject(s)
Search on Google
Add to My VHL
Print
XML
PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Echocardiography / Contrast Media / Fluorocarbons / Heart Ventricles Type of study: Clinical_trials Limits: Adult / Humans / Male Language: En Journal: Invest Radiol Year: 1997 Document type: Article Affiliation country: Country of publication:
Search on Google
Add to My VHL
Print
XML
PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Echocardiography / Contrast Media / Fluorocarbons / Heart Ventricles Type of study: Clinical_trials Limits: Adult / Humans / Male Language: En Journal: Invest Radiol Year: 1997 Document type: Article Affiliation country: Country of publication: